Keyphrases
Neuronal Nitric Oxide Synthase (nNOS)
100%
Diabetic Rats
100%
Advanced Glycation End Products
100%
Diabetes
44%
Aminoguanidine
44%
ALT-711
44%
Immunohistochemistry
22%
Experimental Diabetes
22%
Quantitative PCR
11%
Immunocytochemistry
11%
Western Blotting
11%
MRNA Level
11%
Diabetes Complications
11%
Non-enzymatic Glycation
11%
Healthy Controls
11%
Gastrointestinal Complications
11%
Sandwich ELISA
11%
Receptor for Advanced Glycation End Products
11%
Drinking Water
11%
Dependent Processes
11%
Product Formation
11%
Enhanced Accumulation
11%
Enteric Infections
11%
Streptozotocin-induced Diabetic Rats
11%
Gastrointestinal Dysfunction
11%
Product Level
11%
Cross-link Breakers
11%
Nitrergic System
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Advanced Glycation End Product
100%
Neuronal Nitric Oxide Synthase
100%
Aminoguanidine
44%
Experimental Diabetes Mellitus
22%
Messenger RNA
22%
Receptor
11%
Digestive System Function Disorder
11%
Western Blot
11%
Streptozotocin
11%
ELISA Sandwich
11%
Advanced Glycation End Product Receptor
11%
Neuroscience
Neuronal Nitric Oxide Synthase
100%
Diabetes Mellitus
100%
Advanced Glycation End Product
100%
Immunohistochemistry
22%
Messenger RNA
22%
In Vivo
11%
In Vitro
11%
Immunocytochemistry
11%
Real-Time Polymerase Chain Reaction
11%
Streptozotocin
11%
ELISA
11%
Advanced Glycation End Product Receptor
11%
Western Blotting
11%
Receptor
11%
Biochemistry, Genetics and Molecular Biology
Advanced Glycation End-Product
100%
Nitric Oxide Synthase
100%
Messenger RNA
20%
Immunocytochemistry
10%
Cross-Link
10%
Streptozotocin
10%
Real-Time Polymerase Chain Reaction
10%
Glycation
10%
Western Blotting
10%